ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Nabla
Nabla is a healthcare AI company developing an intelligent assistant that streamlines clinical workflows and enhances patient care. They focus on creating innovative solutions that restore human connection in medicine through machine learning.
Nabla is a Clinical AI Layer for healthcare, providing ambient documentation, dictation, and coding solutions embedded within Epic and major EHRs to streamline clinical workflows. Deployed in 130+ health organizations and trusted by 85,000+ clinicians, Nabla automatically captures patient-clinician conversations to generate structured clinical notes, offers clinical-grade speech recognition, and delivers E/M and ICD-10 coding suggestions. The platform is designed to reduce clinician burnout, improve patient-clinician interactions, and support over 20 million patient encounters annually.
STATHealth AI startup to benefit from $1 billion funding round for Yann LeCun’s AMI
2 days ago
HIT ConsultantAMI Raises $1.03B to Build 'World Models': How Nabla is Powering the Next Generation of Healthcare AI
2 days ago
PR NewswireNabla Raises $70M Series C to Deliver Agentic AI to the Heart of Clinical Workflows, Bringing Total Funding to $120M
Jun 17, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nabla.
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
Oct 14, 2025
